Abbott Laboratories has committed €85 million to expand its manufacturing plant in Sligo, Ireland, which it expects will create up to 175 “highly skilled” jobs.
The expansion will provide additional space for manufacturing with positions created in engineering, quality, pharmaceutical science and other science-based areas.
Azita Saleki-Gerhardt, President of Global Pharmaceutical Operations at Abbott, said that the Sligo site is an important part of the company’s manufacturing network.
Abbott, which employs nearly 4,000 people across Ireland, expects the expansion to be completed by 2014 and to create 150 temporary construction jobs to complete the project.
It says the expansion is required to support the company’s “pipeline in the key therapeutic areas of virology, oncology and nephrology”.
The investment is supported by the IDA Ireland, the country’s investment promotion agency. Barry O’Leary, the IDA’s Chief Executive, said the pharmaceutical company is “of key importance to Ireland’s life sciences sector” and is “hugely important to the local economy”.
Subscribe